GANX GAIN THERAPEUTICS INC: institutional ownership and insider trading
51 funds reported holding $19.5M of GAIN THERAPEUTICS INC in their latest 13F filings; in Q2 2026 funds net bought $994K, with 12 new positions and 4 funds selling out.
Famous investors holding GANX
- David Einhorn (Greenlight Capital): $1.15M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $396K, 0.0% of the portfolio
Largest institutional holders of GANX
- MARSHALL WACE, LLP — $3.90M
- Potomac Capital Management, Inc. — $1.92M
- VANGUARD GROUP INC — $1.84M
- GSA CAPITAL PARTNERS LLP — $1.28M
- Cambridge Investment Research Advisors, Inc. — $1.15M
- DME Capital Management, LP — $1.15M
- JONES FINANCIAL COMPANIES LLLP — $1.07M
- VANGUARD CAPITAL MANAGEMENT LLC — $975K
- GEODE CAPITAL MANAGEMENT, LLC — $921K
- BlackRock, Inc. (BLK) — $558K